NCT03909685

Brief Summary

Students are one of the most at-risk groups for mental illness and suicide. Up to 40% of persons with serious mental illnesses do not receive care or stop intervention programs due to negative stigma. Focusing on students, only 30% of universities provide mental health counseling as part of universities' student health services. There is an urgent need to better understand and manage the mental health burden among students. The investigators will use a mental health-focused application that utilizes artificial intelligence to identify symptoms and provides targeted, tailored in-person therapy solutions for its users. Once a patient is matched with a therapist, the application provides solutions to supplement ongoing in-person psychotherapy. This includes journaling and daily assessments that provide curated content and feedback. The current feasibility study aims to recruit 45 Johns Hopkins graduate students with at least mild depressive and/or anxiety symptoms who will be consented and enrolled in a five-week study. There are two study arms: (1) the intervention arm and (2) a waitlist control arm. During the course of the study, the participants in the intervention arm will use the application daily. Participants will receive weekly in-person psychotherapy for a total of four sessions over four weeks. Licensed therapists will provide the in-person psychotherapy. The participants in the waitlist arm will serve as controls unless there is attrition from the intervention group at which time waitlist participants will be offered a spot in the intervention arm. The primary objectives of the study are (1) To assess the usability of the application and (2) To evaluate the short-term impact on mood and anxiety of using the application to augment in-person psychotherapy.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2022

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 10, 2019

Completed
3.2 years until next milestone

Study Start

First participant enrolled

July 1, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 26, 2022

Status Verified

December 1, 2021

Enrollment Period

5 months

First QC Date

April 8, 2019

Last Update Submit

August 23, 2022

Conditions

Outcome Measures

Primary Outcomes (5)

  • Average session time when using the mobile app

    Over the 5 weeks of the study, the mobile app will collect time (seconds) the user spends within each session. We will calculate the average time the user spent on mobile app in each session.

    5 weeks

  • Time of day the mobile app is used

    Over the 5 weeks of using the mobile app, we will capture the time of data the app was used in ( morning, afternoon and evenings). We will derive proportions for the app use at these times of day

    5 weeks

  • Most commonly used feature within the app

    For each session, the app keeps track of different in-app features that are used (mood meter, journal, insights, assessments). Over the 5 week period, we will rank the most commonly used features.

    5 weeks

  • Change in Short term impact on mood as assessed by the Positive and Negative Emotions Scale (PANAS)

    The PANAS is a self-report questionnaire that consists of two 1-item scales to measure both positive and negative affect. Each item is rated on a 5-point scale of 1 (not at all) to 5 (very much).

    Baseline, 5 weeks

  • Change in Short term impact on anxiety as assessed by the General Anxiety Disorder-7 (GAD-7) scale

    The GAD-7 is a self-administered 7 item instrument that uses some of the DSM-V criteria for anxiety to identify probable cases of GAD along with measuring anxiety symptom severity. Responders are asked to rate the frequency of anxiety symptoms in the last 2 weeks on a Likert scale ranging from 0-3.Severity can be determined by examining the total score. A meaningful change is 5 or more points.

    Baseline, 5 weeks

Study Arms (2)

the intervention arm

EXPERIMENTAL

During the course of the study, the participants in the intervention arm will use the Ask RoSE application daily. Participants will receive weekly in-person psychotherapy for a total of four sessions over four weeks. Licensed therapists will provide the in-person psychotherapy

Behavioral: Mobile Mental Health App

a waitlist control arm

NO INTERVENTION

The participants in the waitlist arm will serve as controls unless there is attrition from the intervention group at which time waitlist participants will be offered a spot in the intervention arm

Interventions

The Mobile Mental Health App is an app that utilizes artificial intelligence to identify symptoms and provides targeted, tailored solutions for its users.

the intervention arm

Eligibility Criteria

Age21 Years - 28 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • English speaking;
  • years of age;
  • Full time Johns Hopkins University graduate student;
  • Score \>5 on PHQ-9 and/or \>5 on GAD-7;
  • Have accessible smartphone with data plan;
  • Ability to dedicate one hour a week for therapy sessions;
  • Ability to give informed consent and understand the tasks involved.

You may not qualify if:

  • Not living in Baltimore or surrounding counties as this will make it difficult to schedule on-campus therapy sessions;
  • Part-time students;
  • Students currently receiving psychiatric care.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (7)

  • Wilcox HC, Arria AM, Caldeira KM, Vincent KB, Pinchevsky GM, O'Grady KE. Prevalence and predictors of persistent suicide ideation, plans, and attempts during college. J Affect Disord. 2010 Dec;127(1-3):287-94. doi: 10.1016/j.jad.2010.04.017. Epub 2010 May 14.

    PMID: 20471691BACKGROUND
  • Auerbach RP, Alonso J, Axinn WG, Cuijpers P, Ebert DD, Green JG, Hwang I, Kessler RC, Liu H, Mortier P, Nock MK, Pinder-Amaker S, Sampson NA, Aguilar-Gaxiola S, Al-Hamzawi A, Andrade LH, Benjet C, Caldas-de-Almeida JM, Demyttenaere K, Florescu S, de Girolamo G, Gureje O, Haro JM, Karam EG, Kiejna A, Kovess-Masfety V, Lee S, McGrath JJ, O'Neill S, Pennell BE, Scott K, Ten Have M, Torres Y, Zaslavsky AM, Zarkov Z, Bruffaerts R. Mental disorders among college students in the World Health Organization World Mental Health Surveys. Psychol Med. 2016 Oct;46(14):2955-2970. doi: 10.1017/S0033291716001665. Epub 2016 Aug 3.

    PMID: 27484622BACKGROUND
  • Visnjic A, Velickovic V, Sokolovic D, Stankovic M, Mijatovic K, Stojanovic M, Milosevic Z, Radulovic O. Relationship between the Manner of Mobile Phone Use and Depression, Anxiety, and Stress in University Students. Int J Environ Res Public Health. 2018 Apr 8;15(4):697. doi: 10.3390/ijerph15040697.

    PMID: 29642471BACKGROUND
  • Malinauskas R, Dumciene A, Sipaviciene S, Malinauskiene V. Relationship Between Emotional Intelligence and Health Behaviours among University Students: The Predictive and Moderating Role of Gender. Biomed Res Int. 2018 Jun 4;2018:7058105. doi: 10.1155/2018/7058105. eCollection 2018.

    PMID: 29967780BACKGROUND
  • Moreland JJ, Coxe KA, Yang J. Collegiate athletes' mental health services utilization: A systematic review of conceptualizations, operationalizations, facilitators, and barriers. J Sport Health Sci. 2018 Jan;7(1):58-69. doi: 10.1016/j.jshs.2017.04.009. Epub 2017 Apr 28.

    PMID: 30356496BACKGROUND
  • Kroenke K, Wu J, Yu Z, Bair MJ, Kean J, Stump T, Monahan PO. Patient Health Questionnaire Anxiety and Depression Scale: Initial Validation in Three Clinical Trials. Psychosom Med. 2016 Jul-Aug;78(6):716-27. doi: 10.1097/PSY.0000000000000322.

    PMID: 27187854BACKGROUND
  • Allan NP, Lonigan CJ, Phillips BM. Examining the Factor Structure and Structural Invariance of the PANAS Across Children, Adolescents, and Young Adults. J Pers Assess. 2015;97(6):616-25. doi: 10.1080/00223891.2015.1038388. Epub 2015 May 15.

    PMID: 25975209BACKGROUND

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Paul Kim, MD, PhD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: The current study aims to recruit 45 Johns Hopkins graduate students (initially from Carey Business School) with at least mild depressive and/or anxiety symptoms who will be consented and enrolled in a five-week study. There are two study arms: (1) the intervention arm and (2) a waitlist control arm. During the course of the study, the participants in the intervention arm will use the Ask RoSE application daily. Participants will receive weekly in-person psychotherapy for a total of four sessions over four weeks. Licensed therapists will provide the in-person psychotherapy. The participants in the waitlist arm will serve as controls unless there is attrition from the intervention group at which time waitlist participants will be offered a spot in the intervention arm.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 10, 2019

Study Start

July 1, 2022

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

August 26, 2022

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share